What drugs target JAK1 and JAK2?

2+ drugs target JAK1 and JAK2, including .

What drug classes act on JAK1 and JAK2?

Drug classes acting on JAK1 and JAK2 include JAK inhibitor.

2 drugs 2 in Phase 3

All drugs that target JAK1 and JAK2 — marketed and clinical-stage. Includes 1 drug classes acting on this target.

high dose ruxolitinib · Beijing Friendship Hospital · JAK inhibitor · Oncology, Immunology
Ruxolitinib is a Janus kinase (JAK) inhibitor that blocks the activity of JAK1 and JAK2 enzymes, which play a key role in the signaling of various cytokines involved in inflammation and immune responses.
low dose ruxolitinib · Beijing Friendship Hospital · JAK inhibitor · Oncology
Ruxolitinib is a Janus kinase (JAK) inhibitor that blocks the activity of JAK1 and JAK2 enzymes, which play a key role in signaling pathways involved in inflammation and immune responses.